Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3118 |
|
| Actual shortage: | 249 (8%) | |
| Anticipated shortage: | 11 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2849 (91%) | |
Discontinuation Reports |
355 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 333 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Actual shortage | 2024-07-25 | 2024-07-25 | 233709 |
| APO-CEFADROXIL | 500MG | CAPSULE | Actual shortage | 2024-07-25 | 2024-07-25 | 233706 |
| APO-BACLOFEN | 10MG | TABLET | Actual shortage | 2024-07-25 | 2024-07-25 | 233703 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Actual shortage | 2024-07-25 | 2024-07-25 | 233700 |
| APO-ALLOPURINOL | 100MG | TABLET | Actual shortage | 2024-07-25 | 2024-07-25 | 233697 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-07-18 | 2024-07-18 | 233358 |
| APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2024-07-18 | 2024-07-25 | 233349 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-07-18 | 2024-07-25 | 233346 |
| APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Actual shortage | 2024-07-18 | 2024-07-18 | 233343 |
| APO-ALLOPURINOL | 200MG | TABLET | Actual shortage | 2024-07-18 | 2024-07-18 | 233336 |
| APO-HYDROXYQUINE | 200MG | TABLET | Actual shortage | 2024-07-18 | 2024-07-25 | 233330 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-07-18 | 2024-07-18 | 233325 |
| APO-DEFERASIROX (TYPE J) | 360MG | TABLET | Actual shortage | 2024-07-18 | 2024-07-18 | 233321 |
| APO-LORAZEPAM | 1MG | TABLET | Actual shortage | 2024-07-12 | 2024-07-12 | 232846 |
| APO-DABIGATRAN | 150MG | CAPSULE | Resolved | 2024-07-12 | 2024-07-19 | 232842 |
| APO-LETROZOLE | 2.5MG | TABLET | Actual shortage | 2024-07-12 | 2024-07-25 | 232838 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Actual shortage | 2024-07-12 | 2024-07-12 | 232835 |
| APO-FAMCICLOVIR | 500MG | TABLET | Actual shortage | 2024-07-12 | 2024-07-12 | 232832 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-07-12 | 2024-07-26 | 232829 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-07-12 | 2024-07-26 | 232826 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NITRAZEPAM | 10MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1117 |
| APO-NITRAZEPAM | 5MG | TABLET | Discontinued | 2017-03-13 | 2018-12-07 | 1110 |
| APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
| APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |
| APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
| APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
| APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
| APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |